This Sci-Fi Anti-Cancer Cap Is Producing Impressive Results

American Brain Tumor Association president and CEO, Elizabeth Wilson, commented, “We are excited that combination therapy with Optune plus temozolomide continues to show a meaningful extension of long-term survival for newly diagnosed GBM patients”.

The device, which costs $21,000 (£16,800) a month, has been developed by a Jersey-based company Novocure and is sold in the US, Germany, Switzerland and Japan to adults with glioblastoma multiforme, an aggressive cancer.Dr. Roger Stupp, professor of Neurological Surgery at Northwestern University, is excited by the study’s findings.

Novocure justifies the price tag by citing the 17 years of research and development but they will make the treatment free for patients on Medicaid. Those who used the cap had a median overall survival of 21 months, compared to 16 months for those who didn’t. Unfortunately Optune does not come cheap at $700 a day.

Read more: This Sci-Fi Anti-Cancer Cap Is Producing Impressive Results

Don’t forget to share this via , , Google+, Pinterest, LinkedIn, Buffer, , Tumblr, Reddit, StumbleUpon and Delicious.

Mike Rawson

Mike Rawson has recently re-awoken a long-standing interest in robots and our automated future. He lives in London with a single android - a temperamental vacuum cleaner - but is looking forward to getting more cyborgs soon.

Leave a Reply

Your email address will not be published. Required fields are marked *


This Sci-Fi Anti-Cancer Cap Is Producing Impressive Results

by Mike Rawson time to read: 1 min
Hi there - can I help you with anything?
[Subscribe here]
More in IoT, News
Novelist who inspires Elon Musk
The novelist who inspired Elon Musk | 1843

Elon Musk, the world’s most restless entrepreneur, has embarked on yet another venture. Not satisfied with reusable rockets, electric cars,...